Tags: Drug.
Pitrakinra (trade name Aerovant) is a human recombinant protein. It is an interleukin 4 (IL-4) and interleukin 13 (IL-13) antagonist that has been studied in phase III clinical trials for the treatment of asthma. The drug has been applied both as a subcutaneous injection and as an inhalation but the latter formulation proved to be more effective.